Media Release

Dr Kenneth Tsang, Chief Executive Officer of Gleneagles (middle), Dr Karen Chan (2nd from the right) and Dr Ng Tong-yow (2nd from the left), Co-Directors of Gleneagles’ Gynaecological Oncology Centre, and recovered patients Jade (1st from the right) and Ms Chong (1st from the left)

(9 March 2023 – Hong Kong) Gleneagles Hospital Hong Kong’s (Gleneagles) Gynaecological Oncology Centre provides one-stop medical services for gynaecological cancer patients. The Centre introduces novel surgical technologies, including state-of-the-art robotic and endoscopic systems, hoping to provide precise and advanced treatment for patients. Leveraging the launch of the Centre, Gleneagles aspires to become a research, application and teaching centre for advanced robotic and laparoscopic systems.

Dr Kenneth Tsang, Chief Executive Officer of Gleneagles, said, “The multi-disciplinary team of our Gynaecological Oncology Centre provides comprehensive diagnostic services and personalised cancer treatments for patients. The Centre is supported by our Gynaecological Oncology Tumour Board which discusses each patient case thoroughly to ensure they receive safe and effective treatments and procedures.”

“Gleneagles has introduced innovative and advanced equipment and technology in our various service areas. Our Gynaecological Oncology Centre adopts the latest surgical robotic systems in gynaecological cancer, providing more treatment options for patients. In the long run, our aim is to become a regional leader in advanced gynaecological oncology services. Through participation in clinical research on and development of cutting-edge equipment and surgery, and fostering professional and academic exchanges, we aspire to become a research, application and teaching centre for advanced robotic and laparoscopic systems,” he added.

“Our Gynaecological Oncology Centre’s team comprises doctors of different specialties, such as gynaecological oncology, clinical oncology, radiology, anaesthesiology, colorectal surgery, pathology; as well as nurses and allied healthcare professionals. Members of our Gynaecological Oncology Tumour Board meet regularly to discuss each of the gynaecological cancer cases thoroughly and audit all treatments to ensure the quality of services,” remarked Dr Karen Chan, Co-Director of Gleneagles’ Gynaecological Oncology Centre.

Enhanced patient recovery with novel equipment and medical technologies

Dr Ng Tong-yow, Co-Director of Gleneagles’ Gynaecological Oncology Centre, said, “Gynaecological cancer surgery continues to develop, and now the adoption of innovative technologies can minimise postoperative pain, enhancing patient recovery. For instance, the latest robotic endoscopic system, combined with a 3D high-definition imaging system and an articulated front camera can help improve advanced laparoscopic surgery. The surgery evolving from multiport to single incision (SILS) and Vaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) can reduce blood loss and postoperative pain, shorten hospital stay and speed up recovery.”

Single incision laparoscopic surgery only requires 1.5 cm to 2.5 cm incision through umbilicus, allowing surgical instruments of 5 mm to 12 mm to pass through. Extracorporeal resection can be performed after retrieval of specimens. As specimens will be contained in a bag, there will be no spillage inside abdomen to ensure safety. Another surgery, vNOTES, does not even require any incisions on the body surface. In addition, the latest robotic surgery allows doctors to perform operations with precision, flexibility and control, which result in reduction of blood loss, postoperative pain and complications that facilitate faster recovery of patients.

Dr Ng reminded that as individual patient’s actual condition is different, patients should discuss with their doctor to choose the treatment suitable for them.